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Abstract. Needle biopsy is widely used to obtain specimens
for physiological, anatomical and biochemical studies of
skeletal muscle (SM). We optimized a procedure which we
termed tiny percutaneous needle biopsy (TPNB), to efficiently
gather good numbers of human satellite cells and single
dissociated fibers for the functional study of skeletal muscle;
these samples permit isolation of high-quality RNA and
sufficient amounts of proteins to allow molecular analysis.
Moreover, TPNB showed a clear advantage in that the
technique was easier than other procedures used on healthy
volunteers in human trials. TPNB is a very safe minor surgical
procedure. It is less traumatic than needle aspiration biopsy,
and significant complications are improbable. TPNB should
become established as an important tool in the investigation
of SM and may be employed to study various physiological
aspects of SM in human subjects. We suggest that TPNB
should also be used in the study of muscle diseases and
disorders including muscular dystrophy, congenital myopathy,
and metabolic defects.
Introduction
Molecular and cellular studies on the skeletal muscle (SM) of
humans have been conducted for many years using samples
obtained principally from the Vastus Lateralis (VL) muscle.
Classically, muscle biopsy is an open procedure in which
both the skin and the muscle are cut by a scalpel. Next, a
needle connected to a vacuum pump is inserted to aspirate
muscle tissue (1-3). This technique is still applied in most
muscle laboratories (4), and is termed needle aspiration biopsy
(NAB). Today, other biopsy techniques are also used to
obtain muscle samples prior to genetic (5) and enzymatic (6)
analyses. Studying muscle for many years, we have devoted
attention to human SM, particularly in efforts to study the
muscle's regenerative capacity at different ages and to evaluate
the contribution of oxidative stress to regulation of sarcopenia
(7-10). In these works, we have used human VL or Gluteus
Medium muscle samples obtained during orthopedic surgery
or by employing NAB with application of Liverpool or
Edwards needles, as described by Dietrichson et al (11) and
Edwards (3).
In the past 4 years we have developed a multidisciplinary
project exploring SM adaptation of young and elderly people
to different training regimens. In this work, it was necessary
to perform at least two muscle biopsies (before and after
training), and sometimes three (an extra biopsy on follow-
up), to compare data from the same muscle over time. In
particular, our interest has been focused on the fiber
regeneration due to the activation of adult stem cells of the
SM, the satellite cells (SC) (12,13). Most potential subjects
who were interviewed declined to participate in the project
because they feared the discomfort associated with NAB.
To solve this problem, we decided to test a Tru-Cut semi-
automatic needle for use in SM needle biopsy. This device
has already been employed to sample various tissues including
the liver, the mammary gland, the breast, the prostate (14-16),
and the muscle (17). Indeed, Magistris et al (18), used an
automatic biopsy device to sample SM in the course of histo-
logical and genetic studies. Encouraged by the fact that this
technique was largely used, and also because consent to the
procedure was readily obtainable from both young and elderly
volunteers, we evaluated the use of a tiny biopsy needle to
study cellular and molecular aspects of SM in both the young
and the elderly. We decided to use a semi-automatic device
featuring a 13-gauge needle. We modified and optimized the
procedure and here term the technique tiny percutaneous
needle biopsy (TPNB).
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In the present report, we describe this easy method, and
compare the results obtained from TPNB samples with those
from tissue harvested using NAB. We focus particularly on SC
recovery and RNA and protein yield.
Materials and methods
Subjects. We enrolled 34 volunteers 20-75 years of age to
obtain either NAB or TPNB samples as part of a study on
SM adaptation. Each subject was randomly selected to
undergo a specific needle biopsy procedure, NAB or TPNB,
as shown in Table I, which also contains anthropometric
data. Each subject provided written informed consent for
both NAB and TPNB. The study was approved by the Ethics
Committee of the University G. d'Annunzio Chieti-Pescara,
Chieti, Italy (protocol nos. 1233/06 COET dated 25 July
2006; 1884 COET dated 15 May 2009; and 1634/08 COET
dated 24 June 2008). Sampling was performed at the Clinical
Research Center of the G. d'Annunzio Foundation.
TPNB and NAB devices. A Precisa needle model 1310 (HS
Hospital Service SpA, Latina, Italy) of a 13-gauge diameter
and with an insertion cannula 100 mm in length, was used
(Fig. 1). This is a semi-automatic needle in which a cannula
contains the outer rod and an inner notched cylinder permitting
unhooking, and is used to cut, trap, and withdraw a tissue
sample. A spring system allows automatic advancement of
the inner notched cylinder within the external cylinder inserted
into the skin; the inner cylinder travels below the fascia and
into the muscle. Insertion depth can be monitored by reference
to notches in the external cannula (Fig. 1). We termed this
procedure TPNB, to distinguish it from NAB. In general, the
TPNB procedure consists of insertion of the needle into the
muscle (without cutting the skin with a scalpel), triggering of
the spring (the inner cannula is now inserted into the muscle
to a depth of 2-3 cm), release of the outer cannula (which
works like a guillotine to cut the muscle fibers), extraction of
the inner cannula (Fig. 1) and retrieval of the muscle piece in
a sterile manner. It is important to note that TPNB permits
multiple sampling if the outer cannula remains inserted into
the tissue, because the inner cannula can simply be removed
and re-inserted. Each stick-shaped piece of SM is removed
from the notch of the inner rod using sterile tweezers, collected
into an appropriate solution, and either immediately delivered
to the laboratory for examination according to a specific
protocol or properly stored.
An Edwards needle (Fig. 1) is composed of four parts: an
outer cannula with a grooved window at the tip, an inner tube
or guillotine, a cylinder through which muscle is pulled out
of the inner tube at the conclusion of sampling, and a vacuum
pump. The needle is passed through a skin incision and next
through the fascia, with the aperture closed. When the muscle
is entered, the aperture is opened by withdrawal of the inner
tube, and next closed, trapping a sample of muscle in the
barrel. Aspiration using a vacuum pump is essential to trap
muscle in the groove of the outer cannula prior to cutting
with the guillotine (11). The TPNB procedure is also cheaper
than the NAB procedure. In fact, the TPNB needles were
sterile disposable while the Edwards needle are handmade
devices that have to be cleaned, sterilized, made RNAse and
protein free prior to each use (a time consuming preparation
procedure).
Surgical aspects. TPNB is usually performed under local
anesthesia employing 2 ml xylocaine (1-2%, v/v) after skin
sterilization with Betadine. The needle direction is commonly
perpendicular to the VL upon piercing of the fascia and
insertion is in the muscle belly. Each muscle sample is obtained
by release of a trigger that unloads the spring and activates
the needle. The entire procedure can be performed using one
hand and takes a few seconds.
Injection of an anesthetic may cause a brief burning or
stinging sensation before the area becomes numb. After the
anesthetic wears off, the area may be sore for some hours, or
(rarely) for 1-2 days. Usually, minimal or no discomfort is
experienced during biopsy. A sensation of pressure or tugging
PIETRANGELO et al:  TINY NEEDLE BIOPSY OF SKELETAL MUSCLE362
Table I. Anthropometric data of young and elderly volunteers.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Age (years) Height (m) Weight (kg) % Body fat Isometric force (N)
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
TPNB
Old male (n=8) 64.1±1.2 1.70±0.04 72.9±3.9 21.7±2.5 734.8±68.1
Young male (n=5) 38.6±5.6 1.70±0.04 77.4±7.1 23.4±2.6 1,076.2±68.8
Old female (n=2) 65.5±0.5 1.50±0.07 79.5±14.3 36.7±8.2 322.0±43.0
Young female (n=2) 40.0±2.0 1.74±0.07 58.8±5.0 31.3±5.0 404.0±54.0
NAB
Old male (n=5) 70.8±1.1 1.67±0.05 74.3±7.03 28.2±2.8 593.0±86.3
Young male (n=5) 37.2±3.0 1.70±0.03 77.1±6.6 26.1±2.3 907.7±37.7
Old female (n=2) 60.5±7.5 1.57±0.05 55.2±2.2 35.4±4.7 325.3±45.3
Young female (n=5) 42.7±3.5 1.60±0.06 70.5±13.3 35.7±7.2 442.0±47.0
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
The table shows the means (with standard errors) of age, height, weight, % body fat, and isometric strength peak measured in the dominant
leg of young and elderly male and female volunteers.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
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may be reported. As with any surgical procedure, compli-
cations are possible. Fortunately, major complications after
TPNB are uncommon. Bleeding after the extraction of the
needle is the most usual complication and a slight bruise may
rarely be evident. Infection is a rare complication that readily
responds to treatment.
Patient preparation before TPNB is routine, including: i) no
use of aspirin or aspirin substitutes (e.g. ibuprofen, naproxen)
for 1 week before the procedure, ii) no food for a few hours
prior to the procedure, iii) completion of routine blood tests,
including a clotting profile, 2 weeks before the biopsy, iv)
suspension of blood anticoagulant medications, and perhaps,
v) institution of antibiotic prophylaxis. The physician has
ascertained that the patient has not had an allergic reaction to
the anesthetic.
Before TPNB, vital signs (e.g., pulse, blood pressure, and
temperature) should be measured. The skin above the area to
be biopsied, previously depilated and outlined with a dermo-
graphic pen, is swabbed with an antiseptic solution and
draped with sterile surgical towels. The skin may be numbed
with a local anesthetic. We do not consider it necessary to
inject anesthetic into the muscle because TPNB does not cause
muscle pain and any possible chemical artifacts caused by
anesthetic are avoided. Biopsy of the VL muscle is performed
at a level about one-third of the distance from the upper
margin of the patella to the trochanter major. The choice of
this position was motivated by anatomical considerations; the
area lacks significant neurovascular structures. The needle is
inserted perpendicularly to the skin, and entry into the muscle
is accompanied by a slight resistance that can be felt by the
operator. To verify the depth to which the needle is inserted,
it is useful to refer to the scale rod on the cannula (Fig. 1).
Echographic assistance is necessary in patients with severe
muscle atrophy.
After removal of the outer cannula, sterile gauze bathed
in Betadine is applied to the wound for 5-10 min to prevent
bleeding. Next, a simple adhesive bandage is placed to protect
the insertion point. Patients are advised to avoid strenuous
activity for the next 1-2 days.
Human satellite cells. Muscle tissue was collected in a sterile
manner using tweezers and was placed into 10 ml amounts
of sterile medium containing HAM's F-10 medium (Gibco,
Grand Island, NY) supplemented with 50 mg/ml gentamycin,
at 4˚C or on ice. Each sample was stored for a maximum of
24 h at 4˚C followed by treatment to obtain the explants.
SM fragments were manually minced and cultured in plates.
Seven to thirteen days later, the first mononucleated cells
migrated out of explants adherent to plates (9). The explants
were removed from the plates and the cells were counted. At
the first cell passage (when explants were removed), all cell
populations were regarded as being at the one population
doubling level. The number of myogenic cells as a proportion
of the entire cellular population was evaluated at this stage.
The myogenic purity of SC populations was calculated using
desmin as a marker, the expression of which was determined
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Figure 1. The Precisa 1310 and Edwards needles used for the tiny percutaneous needle biopsy (TPNB) and needle aspiration biopsy (NAB), respectively. The
Precisa 1310 has two parts: an outer cannula 10 cm in length and an inner notched rod with a groove 2 cm deep. The Edwards needle has four parts: an outer
cannula, an inner tube, a vacuum pump (insert), and a cylinder to be inserted in the inner tube. The Precisa 1310 is a unique device with a spring to tension the
external cannula (permitting incision to a depth of 1-2 cm) and a button which, when pressed, allows the cannula to spring up. This maneuver traps muscle
into the groove (2 cm in maximal length) that is carved into the inner cylinder (the notched inner rod). The Edwards needle is connected via a pipe to a
vacuum pump. An applied suction of 1.5 atm ensures insertion of muscle into the groove (near the tip of the outer cannula shown in the figure). Next, the
guillotine cuts the muscle. The insert in the left shows the vacuum pump used for NAB. The insert in the right shows the VL fibers obtained by sampling,
after the inner cannula has been extracted through the outer cannula.
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using the D33 antibody (Dako; 1/50 dilution), followed by
immunostaining with a biotin/streptavidin complex (Dako),
as described by Fulle et al (9).
RNA extraction. SM samples were stored in 2X Lysis Buffer
(Applied Biosystems, Foster City, CA) and transported to the
laboratory at -20˚C. Samples were frozen in Lysis Buffer at
-80˚C or immediately homogenized for 3-5 min in 1 ml
TRIzol/50 mg tissue (Invitrogen/Life Technologies) using
an Ultra-Turrax-T8 homogenizer (IKA-Werke, Staufen,
Germany). Total RNA was purified following the standard
TRIzol protocol. Small aliquots of RNA were used both for
quantification and for quality control. High-quality RNA was
processed. RNA aliquots of 2 μg were used for amplification
and labeling prior to application to a high-density oligo-
nucleotide microarray (10,17,23). Aliquots of 2 μg RNA were
used for retrotranscription and loading to multigene arrays
prior to PCR analysis (Applied Biosystems/Life Technologies;
array no. 4342253).
Protein examination. Tissue samples were dissolved in
Laemmli's solution prior to electrophoretic separation (7,17).
Immunoblotting was performed on proteins (50 μg samples)
resolved by 6% (w/v) SDS-PAGE (7). Specific proteins were
immunologically detected and transferred to nitrocellulose
membranes using a semi-dry blotting apparatus. The transfer
current was 500 mA and the transfer time depended on the
protein sample under analysis. Immunoreactive proteins were
detected using an enhanced chemiluminescence technique
(ECL kit; Amersham Pharmacia Biotech) and quantified by
densitometry (Imagemaster IM1D, Amersham Pharmacia
Biotech).
Statistical analyses. Data are expressed as means ± standard
errors. The unpaired Student's t-test, with application of
Welch's correction were used to calculate statistical signifi-
cance. The Prism5 GraphPad software (Abacus Concepts,
GraphPad Software, San Diego, CA) was employed for
statistical analyses. A p-value <0.05 was considered to indicate
statistical significance.
Results
Beginning in 2007, and encouraged by the feasibility of the
TPNB procedure, its efficiency in terms of the amounts of
muscle obtained, and the ease of obtaining informed subject
consent, we proposed the use of TPNB instead of NAB to
subjects whom we interviewed and enrolled an increasing
number of both young and elderly volunteers (currently more
than 34 subjects) in our studies. When the Edwards NAB and
the TPNB procedures are compared, important differences
come out. The first observation is that NAB yielded 55±15 mg
SM that we were accustomed to subdividing into samples for
different experimental tests. Indeed, when muscle samples
were obtained using the NAB procedure, each individual
sample was placed on a sterile surface or into a Petri-dish and
manually subdivided. This caused several problems, including
stretching of the fibers, and an increased probability of loss
of sterility. A muscle sample obtained by NAB is like a cube
with an ~3.5-4.1 mm side and an area of ~15 mm2. Such a
sample is difficult to subdivide along the run of the fibers
because of fiber refolding.
Using TPNB, we obtained several sticks of muscle and
each stick weighed 8±3 mg. After 4-5 consecutive samplings,
we had a total of about 45-55 mg of SM already subdivided
into individual fragments. Thus, we did not need to divide
individual muscle samples. Each sample was a cylinder with a
diameter of approximately 0.9-1.1 mm, with a cross-sectional
area of approximately 0.6 mm2 and a length of about 8-10 mm,
corresponding to the length of the notch on the inner rod.
Despite the small diameter, TPNB specimens are of adequate
size and of good quality.
Our projects feature four different levels of SM investi-
gation, requiring collection of sufficient muscle amounts. First
we need to obtain a good number of SC that will be employed
in exploration of SM regeneration. Secondly, the muscle
amount needs to be sufficient to permit recovery of single
fibers of a length useful in mechanical studies and thirdly to
afford good sample purity facilitating RNA extraction for
genetic and transcriptome analyses. Finally, the amount should
be sufficient to yield good quality protein samples permitting
evaluation of the proteome.
TPNB allows multiple sampling to be performed; the
outer cannula is simply left in place and the inner cannula
can be removed and re-inserted several times into the same
muscle site of the same subject. This is useful in studies with
elderly people who show SM atrophy. We have successfully
obtained SM samples adequate for all of our different experi-
mental protocols. For our work on regeneration, we routinely
obtain 4,500.0±774.6 SC/mg of young human male and female
SM and 7,037.5±2,769.1 SC/mg of elderly human male and
female SM (from each stick of VL weighing about 10 mg).
The SC numbers from NAB sampling average 2,183.8±617.6
SC/mg young human male and female SM and 1,551.8±489.3
SC/mg of elderly human male and female SM (from each
sample of VL weighing about 30 mg). TPNB yields signifi-
cantly higher numbers of SC from young male and female
volunteers compared to the cell numbers obtained using
NAB (p=0.04); whereas, the numbers of SC obtained from
elderly muscles although somewhat higher by TPNB compared
to NAB, do not significantly differ between the two techniques
(p=0.09) (Table II).
As human SC obtained from explants are always conta-
minated with non-myogenic cells, we estimated the myogenic
purity of our cultures by immunocytochemistry for desmin.
The myogenic purity of the SC population by TPNB was
57±16%, thus not differing significantly from the 52±19%
purity obtained by NAB. No purity differences between young
and elderly muscle samples were evident.
The procedure by which SC are obtained from human
samples, involving use of an explant technique, has been
described by Fulle et al (9). To explore whether TPNB yielded
good numbers of SC, we compared the efficiency of TPNB
with that of open surgery using an enzymatic procedure to
obtain SC. We biopsied dog SM using both open surgery and
TPNB, and obtained SC by enzymatic digestion (19,20),
thus, in a manner completely different from the explants used
for processing of human samples. Sterile tissue samples of
the VL (from a male dog 13 years of age) and Biceps Femoris
(from an 8-month-old female dog) were obtained using TPNB.
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Sample weights were 30±3 mg. Sterile muscle tissue samples
of the Rectus Abdominus (1-year-old female dog) and Gluteus
Superficialis (3-year-old female dog) were obtained by open
surgery. The weights of these samples were 100±13 mg.
We obtained 352 SC/mg VL from the 13-year-old dog and
755 SC/mg Biceps Femoris from the 8-month-old dog by
TPNB, and 110 SC/mg Rectus Abdominus from the 1-year-
old dog and 300 SC/mg Gluteus Superficialis from the 3-year-
old dog by open surgery. Although dogs showed differences
in SC yield with age and muscle type, the numbers of cells
obtained using TPNB and open surgery did not differ signifi-
cantly, although the cell numbers obtained by TPNB were
somewhat higher than those yielded by open surgery.
Collaborators of Professor Carlo Reggiani in the University
of Padua, where the mechanical experiments on single fiber
were performed, were able to obtain approximately 500
dissociated fibers from each TPNB sample of either young or
elderly subjects. A high percentage of such fibers were of
lengths greater than 0.5 mm, permitting use of the fibers in
single-fiber mechanical experiments.
We extracted about 15-20 μg high-quality RNA from
each TPNB sample. Table II shows the yields from different
types of samples. This amount of RNA was adequate for
amplification and retrotranscription prior to microarray work,
and permitted protocol validation before use of the polymerase
chain reaction. The difference between RNA content on
muscle samples taken by TPNB and NAB was not significant.
We extracted about 4-6 mg of total proteins from each TPNB
sample (details in Table II). Proteins prepared from TPNB
samples were subjected to gel electrophoresis and Western
blotting. Notably, residual samples after single-fiber dissection
could also be used in protein analysis, as described in Materials
and methods) (7,17). Our collection procedure facilitated the
initial homogenization required for protein solubilization, and
we thus obtained protein quantities that were more than
sufficient for electrophoresis and subsequent immunoblotting.
The difference between protein content of muscle samples
taken by TPNB and NAB was not significant.
Discussion
The TPNB technique has several clear advantages over the
NAB approach, especially with respect to enhanced patient
comfort and the absence of unsightly scarring. TPNB is
recognized as a simple, rapid, and repeatable method useful
to obtain muscle tissue; can be safely performed on an
outpatient basis; and is applicable to subjects of all ages, even
the sarcopenic elderly. These features are fundamentally
important in our work because we can now easily enroll a
large number of volunteers. In the past, it became clear to us
that neither young nor elderly subjects were inclined to
consent to the use of the NAB procedure. Indeed, many
initially interested volunteers developed mistrust and concern,
being particularly distressed when confronted with the ‘huge’
needle used in Edwards NAB (the adjective ‘huge’ was
commonly used by those whom we interviewed). We became
convinced that we had to employ a needle smaller in diameter
than that of the Edwards NAB, but which could nonetheless
give us samples of sufficient quality and quantity to further our
work. We used a semi-automatic needle that had previously
been employed principally in the clinical investigation of
patients with mammary (15), lung (14), or prostate cancer
(16) and also musculoskeletal masses (21), and to obtain
samples for immunocytochemistry and immunohisto-
chemistry. A small automatic needle had earlier been used
for purification of human muscle satellite cells (18). In the
cited report, it was shown that, in those with suspected
muscle disease, enzymatic dissociation yielded about 1,000
myoblasts/15 mg of muscle from patients aged 40 years on
average. It should be noted that the enzymatic procedure
employed in the present work yielded SC numbers from dog
muscle similar to the levels obtained by Magistris  et al (18)
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Table II. Data obtained from TPNB and NAB samples.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Number of human satellite cells/mg SM RNA/SM (μg/mg) protein/SM (μg/mg)
––––––––––––––––––––––––––––––––– ––––––––––––––––––– –––––––––––––––––––––––
TPNB NAB TPNB NAB TPNB NAB
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Old male 6,600.0±3,713.7 1,261.1±223.8* 1.6±0.5 1.9±0.5 551.8±21.5 603.7±34.5
(n=8) (n=5) (n=8) (n=5) (n=8) (n=5)
Young male 3,800.0±406.2 1,610.8±574.7* 2.06±0.9 2.2±0.7 570.0±20.9 550.7±25.7
(n=5) (n=5) (n=5) (n=5) (n=5) (n=5)
Old female 8,350.0±2,350.0 2,133.3±1,539.2 1.9±0.8 1.8±0.4 543.5±36.1 580.7±30.6
(n=2) (n=2) (n=2) (n=2) (n=2) (n=2)
Young female 6,120.0±2,200.0 3,330.0±1,330.0 1.7±0.0 1.7±0.4 469.8±0.0 621.7±42.9
(n=2) (n=5) (n=1) (n=5) (n=1) (n=5)
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
The first part of the table shows the numbers of human satellite cells obtained using tiny percutaneous needle biopsy (TPNB) and needle
aspiration biopsy (NAB), from male and female, young and old, volunteers. The central part of the table shows the yields of RNA, and the
last part of the table the amounts of protein, per mg of Vastus Lateralis (VL). Data are reported as means with standard errors. T-test
analysis showed that the number of SC obtained using TPNB vs. the number of SC obtained using NAB were significantly different when
comparing old to young males (*p<0.05).
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
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from human SM, but our explant approach resulted in human
SC numbers significantly higher than were obtained by
Magistris et al (18). We selected the semi-automatic needle
Precisa 1310 as a preferred device for TPNB sampling of SM.
We optimized the TPNB procedure and recruited a significant
number of healthy volunteers to our projects. Indeed, we are
proud to report that even a top-level athlete volunteered to
undergo TPNB to permit the study of the VL muscle, and that
neither pain nor discomfort was experienced. Exercise physiol-
ogists are aware that it is very difficult to persuade athletes to
submit to muscle biopsy, and also that it is very important to
study the SM of athletes at the cellular and molecular levels
to investigate muscle adaptation to different environmental
conditions. In our view, TPNB optimization may be useful in
the study of SM in various types of subjects, either top-level
athletes, elderly subjects, or patients with muscle pathologies
inducing severe atrophy and even obesity. We are of the view
that TPNB may be a valuable ‘field procedure’. This means
that TPNB can be performed on a subject/athlete (young or
elderly) immediately after a performance (obviously complying
with surgical rules), because the procedure is really easy, safe
and simple.
The value of the TPNB procedure lies not only in its
feasibility but also in the efficiency of the approach in terms
of SC yield. In particular, we demonstrated that TPNB was
effective in sampling of the sarcopenic SM of elderly subjects.
Sarcopenia is a condition defined by progressive atrophy of
SM. It is very difficult to conduct a NAB biopsy on such
muscles, whereas, TPNB is easy. We also used TPNB to
explore severe atrophy of a lower limb in a young subject
(29 years of age) for whom NAB was not practical. We used
echographic guidance to identify and sample the VL muscle
(T. Pietrangelo, personal communication). After we shared
our TNPB experience with colleagues, the technique was used
to sample the Latissimus Dorsi muscle, which is traditionally
difficult to biopsy because the muscle is thin and flat (22).
Our results also confirm that muscle biopsy using TPNB,
yields tissue susceptible to analysis of a wide range of para-
meters, both functional and molecular. Indeed, isolation of SC
and analysis of such cells in excitation-contraction coupling
experiments is one of the most important functional parameters
reflecting the overall condition of SM (12). The high-level
efficiency of TPNB with respect to muscle sampling is of
great importance when it is sought to extend such functional
analyses to (eventually) consider specific pathologies of SM.
The characterization of single fiber mechanics and the
identification of the fiber phenotype are also very helpful.
Moreover, it is very important to adequately describe the
transcriptional profiles of muscle [using oligonucleotide
microarrays, as described by Pietrangelo et al (17,23)],
because the profile changes upon specific conditioning or
under various loads in human muscles of different ages. It is
also interesting to validate any profile obtained by further
quantitative assessment of gene expression using, for example,
multigene arrays combined with real-time PCR. Muscle
protein analysis by electrophoresis and Western blotting of
TPNB samples is efficient. In fact, TPNB collects muscle
fibers that are devoid of fat. In rare instances, TPNB traps
traces of blood vessels. Notably, the yield of SC/mg muscle
was significantly higher by TPNB compared to NAB, probably
because the carving of fibers was associated with a reduced
level of trauma, and only minor quantities of adipose cells
and vessels were collected, making the muscle tissue easily
identifiable. It may also be that TPNB specifically activates
migration of SC, by stimulating the synthesis of specific
cytokines. We are of the view that the presence of thousands
of easily dissociable fibers of 0.3-0.6 mm in length favor the
migration of SC away from the fibers both in explants and
during application of enzymatic techniques used to collect
SC. Furthermore, we note the fact that while excellent for
collecting satellite cells and DNA/RNA, this approach, like
the standard needle biopsy, is not appropriate for in depth
structural analysis.  In fact, the problem in the biopsies arises
from what happens as soon as the needle damage a live muscle
fiber. The fiber is depolarized and it immediately contracts
and quickly relaxes. However, if the fiber is not restrained it
contracts to very short lengths and then it remains shortened.
Moreover, the calcium diffuses in from the cut ends and it
activates more contraction. The diffusion is slow (1 μm/msec)
but it may affect a significant portion of the very short fiber
segments. The fibers are usually contracted and distorted.
Today, the only reliable way to obtain good samples for
morphology is to do a standard biopsy in which a relatively
long bundle is restrained before cutting the ends by a clamp
(24) that keeps the fibers from shortening when cut, and the
centers of the bundles are sufficiently far from the ends that
calcium would take forever to penetrate.
In conclusion, TPNB is a very safe and minor surgical
procedure. It is both less dangerous and less traumatic than
NAB, and significant complications are rare. TPNB should
become established as an important tool for investigating SM
and may be employed to study various physiological and
pathological aspects of muscle even in fragile subjects such
as the elderly. We suggest that TPNB will also be useful in
the study of muscle diseases and disorders such as muscular
dystrophy, congenital myopathy, and metabolic defects.
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